Lamotrigine
Product Images NDC 55648-271

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 55648-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Lamotrigineertabs M Figure 01)

Chemical structure of lamotrigine showing the molecular arrangement including chlorine atoms, amino groups, and a triazine ring.*

FDA Label Image

Figure 1 (Lamotrigineertabs M Figure 02)

A responder rate curve graph comparing Placebo (N=120) and Lamotrigine Extended-Release Tablets (N=116). The y-axis shows responder rate from -100% (worsening) to 100% (improvement), and the x-axis shows percent of patients from 100 to 0. The graph plots responder rates equal or greater than improvement against patient percentage for both groups using dashed and solid lines respectively.*

FDA Label Image

Tablets (Lamotrigineertabs M Figure 03)

This panel describes Lamotrigine extended-release tablets manufactured by Wockhardt Limited. It details five strengths: 25 mg (yellow, circular, debossed with 'W' and '271'), 50 mg (pink, circular, debossed with 'W' and '274'), 100 mg (light brown, circular, debossed with 'W' and '273'), 200 mg (pink, circular, debossed with 'W' and '272'), and 300 mg (pink, circular, debossed with 'W' and '275'). All tablets are enteric-coated.*

FDA Label Image

Label (Lamotrigineertabs M Figure 04)

Label for Lamotrigine Extended-Release Tablets 25 mg by Wockhardt Limited. The label states each extended-release enteric-coated tablet contains 25 mg lamotrigine, with a package count of 30 tablets. It includes storage instructions, a safety warning about the printed safety seal, and a caution to verify the dispensed product. The label features the manufacturer's and distributor's information along with a barcode.*

FDA Label Image

Label (Lamotrigineertabs M Figure 05)

Label for Lamotrigine Extended-Release Tablets 300 mg in a bottle of 500 tablets by Wockhardt Limited. The label includes usage instructions such as once a day dosing, storage conditions, and cautions to verify the product dispensed. It also shows an image of a pink tablet marked 275 and contains the NDC number 64679-275-02.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.